Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Wai Chun Bio-Technology Ltd. ( (HK:0660) ).
Wai Chun Bio-Technology Limited has requested a one-day trading halt in its shares on the Hong Kong Stock Exchange, effective from 9:00 a.m. on 13 April 2026. The suspension is pending the release of an announcement containing inside information, signaling that a potentially material development is forthcoming for shareholders and other market participants.
The move indicates that the company is preparing to disclose price-sensitive information that could affect its valuation or strategic direction. Investors will closely watch the upcoming announcement for clarity on how the undisclosed matter may influence the company’s operations, governance, or financial outlook, and the brief duration suggests a near-term resolution.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded on the Stock Exchange of Hong Kong under stock code 660. The board is led by Chairman and Chief Executive Officer Lam Ka Chun and includes three independent non-executive directors, underscoring a standard corporate governance structure for a small to mid-cap listed firm.
Average Trading Volume: 164,636
Technical Sentiment Signal: Buy
Current Market Cap: HK$45.51M
For detailed information about 0660 stock, go to TipRanks’ Stock Analysis page.